Related Experiment Video
Updated: Jan 6, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
lncRNA TMEM147-AS1 promotes acute myeloid leukemia development by regulating miR-873-3p/ZFX axis
1Department of Blood Transfusion, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, 316000, Zhejiang Province, China.
Abstract:
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy originating from prolonged abnormal proliferation of immature myeloid cells. Long non-coding RNAs (lncRNAs) are important regulators of AML progression. TMEM147-AS1 has been reported to be abnormally expressed in AML. This study aimed to further explore the roles of TMEM147-AS1 in AML and the possible mechanism. The expression of TMEM147-AS1 and miR-873-3p and its role in the clinical progression of AML were investigated. The diagnostic and prognostic value of TMEM147-AS1 in AML was assessed. The impacts of TMEM147-AS1 on AML cell function were examined. And the targeting relationship among TMEM147-AS1, miR-873-3p, and ZFX was predicted by databases and verified by dual-luciferase reporter assay. TMEM147-AS1 was upregulated in AML tissues and cell lines. High TMEM147-AS1 expression was significantly related to adverse karyotype, shorter overall survival time, and worse prognosis in AML patients. And TMEM147-AS1 can distinguish AML patients from healthy individuals with relatively high sensitivity and specificity. Furthermore, TMEM147-AS1 targeted miR-873-3p, which further targeted ZFX. TMEM147-AS1 promoted proliferation and inhibited apoptosis of AML cells through downregulating the inhibitory effect of miR-873-3p on ZFX expression. TMEM147-AS1 promotes AML progression via regulating the miR-873-3p/ZFX axis. TMEM147-AS1 is a promising diagnostic and prognostic indicator in AML.
Insights
Long non-coding RNA TMEM147-AS1 is upregulated in acute myeloid leukemia (AML), promoting cancer progression. This lncRNA serves as a potential diagnostic and prognostic biomarker for AML patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Acute myeloid leukemia (AML) is a complex blood cancer characterized by abnormal myeloid cell proliferation.
- Long non-coding RNAs (lncRNAs) play crucial roles in regulating AML pathogenesis.
- TMEM147-AS1 is a lncRNA previously found to be dysregulated in AML.
Purpose of the Study:
- To investigate the functional role of TMEM147-AS1 in AML progression.
- To elucidate the molecular mechanism underlying TMEM147-AS1's action in AML.
- To evaluate TMEM147-AS1 as a diagnostic and prognostic marker for AML.
Main Methods:
- Quantitative real-time PCR to assess TMEM147-AS1 and miR-873-3p expression in AML tissues and cell lines.
- Bioinformatic analysis and dual-luciferase reporter assays to confirm targeting relationships.
- Cell proliferation and apoptosis assays to evaluate the functional impact of TMEM147-AS1.
Main Results:
- TMEM147-AS1 expression was significantly upregulated in AML tissues and cell lines compared to healthy controls.
- High TMEM147-AS1 levels correlated with adverse cytogenetics, shorter overall survival, and poorer prognosis in AML patients.
- TMEM147-AS1 was found to target miR-873-3p, which in turn targets ZFX, promoting AML cell proliferation and inhibiting apoptosis.
Conclusions:
- TMEM147-AS1 promotes AML progression by modulating the miR-873-3p/ZFX axis.
- TMEM147-AS1 demonstrates potential as a valuable diagnostic and prognostic biomarker for acute myeloid leukemia.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Master Transcription Regulators